93 175 (Quinidine sulfate ER 300 mg)
Pill imprint 93 175 has been identified as Quinidine sulfate ER 300 mg.
Quinidine is used in the treatment of arrhythmia; malaria and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Quinidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
Quinidine sulfate ER
- Imprint:
- 93 175
- Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-9175
- Inactive Ingredients:
- fumaric acid
hypromelloses
lactose monohydrate
magnesium stearate
polydextrose
triacetin
titanium dioxide
More about quinidine
Consumer resources
- Quinidine gluconate controlled-release tablets
- Quinidine sulfate
- Quinidine sulfate controlled-release tablets
- Quinidine
- Quinidine Oral, Injection, Intramuscular (Advanced Reading)
- Other brands: Cardioquin, Quinidex Extentabs, Quin-G
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
